RxDoctor Payments Data

Brycen Witcher

Interventional Pain Medicine · Granbury, TXNPI 1356924476

Payments from drug & device makers

$9,092in general payments, 2019–2025

Across 113 payments — averaging $80.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Medtronic$3K
  • Boston Scientific$2K
  • SPR Therapeutics, Inc$326
  • Spinal Simplicity, LLC$213
  • Nalu Medical, Inc.$146
  • plus $592 from 10 others

What the payments were for

  • Travel & lodging$3,95744%
  • Food & beverage$5,13456%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,092 in reported general payments places this provider in the 55th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin12$18,594
JanuviaSitagliptin Phosphate11$10,092
Gabapentin112$1,985
Fentanyl16$1,949
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen50$1,768
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen93$1,334
Albuterol Sulfate HfaAlbuterol Sulfate27$1,149
Baclofen33$973
Duloxetine Hcl14$964
Nifedipine ErNifedipine35$777
Tamsulosin Hcl25$721
Pregabalin35$563
Tramadol Hcl64$517
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide11$514
Atorvastatin Calcium65$502

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$13$18,59412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 287 interventional pain medicine providers in Texas.

Other interventional pain medicine in Granbury

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →